Catalyst

Slingshot members are tracking this event:

GlaxoSmithKline's (GSK) Influenza Vaccine FluLaval Quadrivalent Approved by FDA for Expanded Use in Children Ages Six Months and Older

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
GSK

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 21, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Influence Vaccine, Flulaval Quadrivalent, Fda, Approval, Expanded Label